Transforming the Boundaries of PerformanceNanophase Technologies: Nanomaterials and Nanotechnology Leader
MarketsApplicationsProductsTechnolgiesCorporateInvestors RelationsEmploymentContact UsSearch





Investors Relations


FIRST QUARTER 2001 CONFERENCE CALL

Joseph Cross, President and CEO

  • Welcome to our first quarter 2001 conference call. We appreciate your continuing interest and support. The Nanophase attendees for this session are: Dan Bilicki, VP Sales and Marketing; Dr. Don Freed, VP Business Development; Dr. Gina Kritchevsky, VP Technology and Engineering; Jess Jankowski, CFO and Corporate Controller; and Bob Haines, VP of Operations, who joined the company during the quarter.

  • To review the quarter, Jess Jankowski will provide a financial summary of results …Jess……….

Jess Jankowski, CFO and Controller

  • Good morning and thank you for attending.

  • Beginning this quarter, in the interest of communicating better with our shareholders, we are going to review the Company's results and financial condition in more detail.

  • For the first quarter of 2001, our revenues were approximately $1,072,000 versus approximately $619,000 for the same quarter in year 2000. The majority of our revenues continue to come from products. Please note that approximately $400,000 of first quarter 2001 product revenue related to the catalyst order that we discussed in our March 28th press release. We had had positive negotiations with that customer for some time prior to finalizing arrangements and were ready to fill the order immediately upon coming to terms. The timing of this revenue seems to have been a point of confusion to some of our shareholders.

  • We had approximately $220,000 in gross margin for the first quarter of this year. This was achieved through a combination of favorable product mix and the fact that we are starting to see many of our manufacturing cost-saving measures coming through. We now feel that gross margins should remain positive through the balance of the year. The extent to which we remain positive, as a percentage of revenue, will be dependent upon revenue mix, revenue volume, and our ability to continue to cut costs. On the bottom line, we lost 8 cents per share for the first quarter of this year versus 11 cents per share for the first quarter of 2000.

  • I would now like to spend a little time walking you through the major categories on the March 31, 2001 balance sheet:

  • All numbers are approximate….
  • At March 31st, we had $14.9million in cash and investments.

  • Accounts Receivable amounted to $1.3million. 96% of our receivables were current. The reason that our receivables appear large in relation to sales are several:

    • First, we have an accrued receivable relating to a minimum royalty due us from a licensee, that amounts to $300,000/year and is accrued at a rate of $75,000 per quarter. Most of these monies are not due until the middle of this quarter. As the quarters go by, this builds our A/R and may lead people unfamiliar with this relationship to assume that we are not collecting on a timely basis. This receivable makes up 28% of our A/R balance.

    • Another reason is that receivables from BASF, currently our largest customer, amounted to 37% of our accounts receivable and have been historically shipped under 60-day terms. Through a series of negotiations, we have been able to reduce these terms to 30-days, beginning this month.

    • Another 30% of our A/R relates to the catalyst order that we filled at the end of the first quarter and discussed earlier. At this time we are not able to discuss customer specifics.
  • What we can discuss however, is that Nanophase is confident that these customers, comprising approximately 95% of our receivables, are financially sound and will be paying us within proscribed terms.

  • I'm sure that you have noticed that inventory has gone up by $500,000 between the end of 2000 and March 31st. This build-up was anticipated and strictly controlled by management. As a matter of fact, we originally planned to exit 2000 with more inventory than we actually did but were stymied by one of the nastiest winters in Chicago's history. On top of the December holiday schedule, we lost at least five shifts due to a combination of travel conditions and the weather's impact on utilities. In January, as many of you may be aware, BASF gave us an updated forecast that shifted much of our anticipated shipping schedule out, putting more weight on the 3rd and 4th quarters. In order to most efficiently manage resources, we will continue to build inventory in Q2 and through part of Q3 so as not to be placed in a "crunch" situation in the latter half of this year. 65% of our total inventory relates to this business. We continue to manage this situation closely.

  • Nanophase, throughout our organization, remains focused on producing as efficiently as possible. When the time comes, we'll increase our capacity, via added manpower, to meet this customer's requirements….but, until then, we'd rather keep our overhead to a minimum. With the improvements made, our existing infrastructure can support this customer's current 2002 forecast.

  • Switching gears to another key area of focus:

  • Capital expenditures amounted to $1million dollars in the first quarter of this year. We anticipate spending an additional $6million in the balance of the year, depending on scheduling. These projects may take us into the first quarter of next year.

  • Most of our spending is earmarked for three main categories:

    • The pilot manufacturing facility in Romeoville
    • The powder coating area in Romeoville (Includes upgrades to existing building utilities, like electrical power and related controls, and other things)
    • Planned capacity expansion to our Burr Ridge facility

  • With respect to the powder coating area, our cash outflows are being offset by a $1.3million dollar loan from BASF upon which we have received roughly 50% and expect to receive the balance shortly.

  • Another thing I would like to address on the March 31st balance sheet is the Company's roughly $1million dollars in long and short-term debt. 65% of this, which is currently classified as long-term, reflects funds received against the previously discussed $1.3million loan. The balance reflects insurance premiums that management elected to finance. Given our current view, we plan to exit this year with between $9 and $10million. That number is a little difficult to determine at this point in our year. Keep in mind that we are currently involved with several business development opportunities whose ultimate magnitude and impact on cash are difficult to gauge. We will update you from time to time if there are significant changes.

  • Lastly, we have also had some increases in our accounts payable. This is mainly a result of both our building inventory and our capital-spending plan.

  • Thanks for your attention, now I'd like to turn things back over to Joseph Cross, our President and CEO.

Joseph Cross, President and CEO

  • Thank you, Jess

  • To summarize first quarter 2001, the management team believes that the quarter was quite successful and provides a sound beginning to the new fiscal year. Despite the unexpected delivery rescheduling for sunscreen materials that occurred during the end of January, Nanophase was still able to achieve a 73% increase in revenues and reduce its loss by approximately 30% compared to the same period last year. Perhaps more significantly, the company was able to demonstrate a positive gross margin on sales of 21%, representing a 50% increase compared to the same period last fiscal year and an approximate 28% improvement to the previous quarter.

  • Gross margin growth is largely due to the company's rigorous efforts over the last 15 months to reduce manufacturing cost through engineering improvements to the process and implementing world-class manufacturing techniques. We have now been able to reduce cost on major products by approximately 50% and increase output per reactor by 30-100% depending on the product. As a secondary, but equally important contributor, we have also been able to obtain higher margin business, primarily in environmental catalysts, and believe that we have additional opportunities to increase sales margins on products in several of the potential business development opportunities currently in process.

  • Addressing infrastructure, we made progress to our plans scaling-up Burr Ridge to have capacity in place for current annual supply agreements and customer forecasts during 2001, as well as into early 2002 as far as we have visibility. The Romeoville upfit remains on schedule as we completed two additional labs and continued readying manufacturing capability for our proprietary nanopowder coating area targeted for June and the pilot area to supply large-scale dispersions and formulations to customers, which should be ready during July.

  • We also executed to our manufacturing plan of building inventory to manage and perform to the projected increased revenue and delivery schedule during the third and fourth quarters of this year. Or goal here is to perform to the customers needs without spending the capital to add peak capacity capability or incurring unnecessary cost in overtime or other variable manufacturing expenses.

  • In business development, we continue to demonstrate progress with a new long-term supply agreement for abrasion-resistant material for vinyl flooring and a new environmental catalyst application. We made sound progress in application engineering developing nanosolutions with lead customers in target markets and toward readying Audrey for commercial production during the third quarter.

  • To elaborate on this topic, I would like Dr. Don Freed, VP Business Development, to provide an update on the company's business development activity, Don.

Dr. Don Freed - Vice President, Business Development

  • Good morning - and thanks for your interest. Despite the economic slowdown, interest in the Company's capabilities to develop unique nanoparticle solutions continues to be strong. During the 1st quarter we initiated new programs in several market areas including environmental catalysts - you've probably read our recent news release on that, as well as transparent functional coatings and electronics.

  • Today, I'd like to focus on our activities in developing transparent, functional coatings, - we believe the programs that we are initiating now will contribute significantly to our revenue and profit targets for 2002 and 2003. But before I do this, I'd like to briefly remind you of just how the Company's business development activities are organized and how we select opportunities.

  • We use two very important criteria to evaluate potential - time-to-market and value - value both to the customer and value to Nanophase. Our time-to-market criteria are 12 to 18 months from project inception to commercial production - and, because our materials are not commodities, but higher priced, uniquely engineered products, our value criteria require that customers gain significant performance advantages from using our nanomaterials.

  • Now, getting back to transparent coatings, let's translate the value criteria to several programs. Nanophase has developed the capability to incorporate nanocrystalline aluminum oxide into a broad range of materials for application such as wear-resistant coatings - we've now taken the technology originally developed for wear-resistant flooring into several new products - We're working with a large manufacturer of specialty fabrics to increase the wear resistance of ballistic nylon and polypropylene - and gained a threefold improvement just by incorporating our nanoparticles into this particular customer's fabric coatings - we haven't changed that material substantially - in fact, because of the small size of our particles, the coating is practically invisible, but products made using this new material should have much better durability and we expect to be selling into this application later this year. We're also co-developing together, with one of the world's largest household appliance manufacturers, transparent wear-resistant protective coatings capable of withstanding elevated temperatures and with more than half a dozen additional companies in applications as diverse as scratchproof coil coatings to wear resistant floor polishes and we expect many of the above-identified opportunities to be realized during the next eighteen months.

  • By focusing our know-how in a concentrated area, we're increasing our chances of success - as we deliver more application solutions to customers, we gain more in-house knowledge (which we protect by filing for patents) and more experience which allows us to tackle more complex problems and most importantly, reduce our time-to-market. And, our available market also grows - to many times that just for the initial applications, which when we started we estimated at $25 - $30 million - we believe the current opportunity in wear-resistant coatings to be more than double that and growing rapidly - in fact, we believe that some day, nanoparticulate-based wear-resistant coatings will form the basis for a separate business unit within Nanophase.

  • Bear in mind that we're not ignoring our other potential and on subsequent calls, we'll cover additional developing market areas so that before very long you'll have the total picture.

  • Now, I'd like to turn it back to Joe Cross - Joe…

Joseph Cross, President and CEO

  • Thanks, Don. Following in line with business development initiatives, Dan Bilicki, vice president of sales and marketing, will now summarize the company's progress during the first quarter. Dan…

Dan Bilicki, VP Sales & Marketing

  • As reported, revenue from Q1 was $1,072 million with $980K or 91% being derived from sales of products. Compared to Q1 of 2000 this is an increase of 73% in revenue and a 101% increase in product sales.

  • Nanophase consistently generates a majority of product sales from the 4 key market segments that include Personal Care, Transparent Functional Coatings, Catalysts, and Ceramics including Thermal Spray. For Q1 2001, of the $980K in product sales 96% were generated from these 4 key market segments.

  • I would now like to provide an update on the progress of product sales by market segment for Q1 and an outlook for Q2.

  • In the Personal Care market segment inventory adjustments and rescheduling off take of ZnO to personal care applications resulted in lower that expected sales volume for Q1. Sales volume of ZnO into the personal care market is expected to exceed last year by 37% resulting in strong demand in Q3 & Q4.

  • Good progress has been made in on the installation of a material handling and proprietary surface treatment system that will allow Nanophase to end our dependence upon a third party and surface treat the ZnO in house. Surface treated ZnO from the Nanophase facility will be shipped to customers for their approval in Q3.

  • As mentioned during last quarter conference call we have 2 other non-ZnO personal care initiatives underway. One of the programs is in the trial stage and is expected to move to the product sales stage in the fourth quarter of this year. The other program proposal is currently under review by senior management with approval expected in Q3.

  • Nanophase has made progress in taking ZnO to horizontal markets outside of personal care; we expect to start selling ZnO into the electronics market in Q3.

  • Transparent functional coating market segment has the highest level of product testing activities of all 4-market segments. As reported last quarter Nanophase has signed up 2 agreements with separate customers for flooring applications. The larger of these two customers has delayed their launch due to circumstances beyond their control. A meeting is scheduled in May to discuss rescheduling the new product launch. Sales revenue for this application has not been included in our current forecast for 2001.

  • Sales to Catalysts applications continue to grow as the company has announced sales of $400,000 to a new environmental catalyst application in Q1. The nano crystalline material provided will be used for large-scale tests. Although this development effort is still in the early stage we expect that significant additional revenues will be generated in 2001 and beyond.

  • In ceramics, Nanophase is currently working with lead customers and leading centers of thermal spray excellence to test and provide comparative analysis of the performance of our products in thermal spray applications. The development of nano chrome oxide for thermal spray applications is proceeding on schedule.

  • In Summary: Q1 product sales were significantly ahead of Q1 last year. An initial sale of product into a new environmental catalyst application is a very encouraging development. Product sales for Q2 are expected to exceed Q1 by 50% as sales volume of ZnO into personal care applications returns to forecasted levels.

  • And now back to Joe

Joseph Cross, President and CEO

  • Thanks, Dan. Now, Dr. Gina Kritchevsky, vice president of Technology and Advanced Engineering, will summarize the company's quarterly technology achievements, Gina.

Dr. Gina Kritchevsky, VP of Technology and Engineering

  • Good morning.

  • During the first quarter of 2001 we have continued to focus much of our advanced engineering efforts on Audrey. For any newcomers to our conference call, Audrey is a new nanoparticle production technology that we have been developing over the past nine months. The goal is to enable us to broaden the range of nanomaterials that we offer in the marketplace and to produce these materials at significantly higher rates than PVS with a wider range of feed materials. During the quarter we have screened over a dozen candidate materials. We continue to be extremely encouraged by both the results and the progress to date. Depending upon the feedstock and the product, rates have varied from two to 10 times the rates for the same material produced by the PVS process. In many instances, the cost of the raw feed material has also been substantially less expensive than the wire and rod feed used in PVS. In several cases, the feed materials have been half or less than half the cost of the feed for PVS.

  • The experience gained in the course of the screening experiments has provided additional insight into the Audrey process. In the second quarter we will implement the equipment and process design improvements derived from our experiences during the initial trials, and will begin to commercialize Audrey processes for several selected materials.

  • Nanophase currently relies on two major complementary core technologies. The first is nanoparticle production and we constantly work to broaden both the range of nanomaterials we produce and the processes that we are able to use to manufacture these particles. Our second core technology involves tailoring the chemistry of the particle surface and the interfacial region between the particles and the material that the particles are imbedded into. This also includes controlling the interactions between particles and the dispersion of the particles into a formulation liquid.

  • Several breakthroughs in our Application Engineering labs during the quarter will enable us to make better particle dispersions and coatings in addition to providing some novel particle chemistries. We expect these breakthroughs to develop into new products during the year. We have also been active during the first quarter in protecting the intellectual property that we have developed in both these core technologies and for applications of our products.

Joseph Cross, President and CEO

  • Thanks, Gina. Now, I would like to introduce Bob Haines, our new vice president of operations, who will give an update on our manufacturing team and the achievements in the first quarter.

Bob Haines, VP of Operations

  • Nanophase is the industry leader in making industrial quantities of nanomaterials, with current manufacturing capabilities of producing at an annualized rate of over 400,000 kilograms. At this level, we have certainly demonstrated that Nanophase has robust manufacturing processes capable of delivering high volumes of quality nano powders.

  • Nanophase had a very strong quarter in terms of our ability to manufacture and deliver high volume, high quality nano powders. Using a lean manufacturing approach focused on continuous improvement, our manufacturing and process engineering team made significant progress in terms of process optimization, reducing manufacturing costs and a notable increase in the productivity of existing manufacturing processes.

  • During the first quarter of this year, our customer service rate was greater than 98.5%. This is a measurement of our actual delivery performance versus commitment as viewed from the customer's perspective. The overall variable manufacturing cost per kilogram of high volume product was reduced by 21% as compared to the last quarter of 2000. In addition, process output in terms of kilograms per hour produced was improved by over 50% without adding additional reactors. With these output improvements, we are able to ramp up zinc oxide production to meet increased third and fourth quarter customer requirements without significant additional capital.

  • Early in January, we introduced a Manufacturing Score Card that focused our operations on real time management of five critical manufacturing performance metrics,
    • Quality / Customer Satisfaction
    • Safety
    • Cost
    • Capital Utilization
    • Productivity
  • We know every shift, every day where we are in terms of these critical performance measurements and where we should be focusing our attention and resources. Our objective is to set the right aggressive goals, frequently measure and communicate our performance against the goals, and continuously improve our manufacturing operations in those areas that actually create value as perceived by our customers.

  • During the first quarter, our Burr Ridge plant was recertified as an ISO9001 manufacturing facility and maintained cGMP status for Zinc Oxide products for the health care industry. Going forward, we will obtain a similar status for the Romeoville coating facility once it is commissioned and producing production quantities of coated zinc oxide.

  • Over this year, we will be bringing on-line additional production capacity for environmental catalysts and precursors for abrasion resistant coatings. We will continue to develop our lean manufacturing approach with a focus on agility to meet our developing customer requirements; having the right manufacturing capacity at the right time with unquestionable quality.

  • Going forward, we will continue to reduce manufacturing costs, improve process yields, and productivity and delight our customers.

Joseph Cross, President and CEO

  • Thanks, Bob.

  • Looking forward into the second quarter, we expect that revenue will increase by at least 50% from first quarter 2001 while variable manufacturing cost and variable expenses will continue to decrease due to continuing aggressive management efforts in those areas. We also expect to close some of our existing business development opportunities during the second quarter, which we believe will contribute to revenue in 2001 and 2002.

  • For this fiscal year, we remain comfortable with our current revenue forecast of approximately $10 million, which would be about 2.4 times 2000 revenue, or an increase of 140%.

  • This concludes our prepared comments. Let me remind you that our comments will be available on our web site, www.nanophase.com, on or about Friday, April 27. We are available for any questions you may have.

FIRST QUARTER CONFERENCE CALL 04-26-01 QUESTIONS & ANSWERS

OPERATOR: Thank you ladies and gentlemen. To ask a question, please press the one key on your touch-tone telephone. If your question has been answered, or you wish to remove yourself from the queue, please press the pound key.

And, if you're using a speakerphone, please lift the handset before you ask your question.

Our first question comes from Donald Hutchinson, of Merrill Lynch, Merrill Lynch & Co. Inc.; Ticker: MER; URL: http://www.ml.com/>.
DONALD HUTCHINSON, MERRILL LYNCH: Good morning, Joe.
CROSS: Good morning.
HUTCHINSON: I just have one quick question. Of the $10 million in sales estimates for the year, is there any portion of that that is due to unannounced new opportunities?
CROSS: Let me answer that two ways. There is some of the forecast that we can't discuss because of secrecy agreements with customers. So, inasmuch as that provides unannounced opportunities, that's true. The opportunities we currently have in business development are not all factored in our current forecast. There are several opportunities that we haven't been able to quantify adequately, at this time and we haven't included in our sales forecast.
HUTCHINSON: So, these - that number then is on folks that we already know that have been announced, in one way or the other - is that right?
CROSS: I would say that is true to a certain extent, but we have factored in closing some business development activities that are very close to the end of the cycle. Those that are close - those that we've got to a point that we think the customer can make an adequate forecast to us, or that we can forecast closely - we've included in the $10 million number. Outside of that, there are several additional opportunities that are not in that $10 million number. But, again, at this time, we haven't been able to adequately quantify those to even consider in a forecast. We would expect, as the year unfolds, that we would continue to fine-tune the $10 million number.
HUTCHINSON: OK. Thank you.
OPERATOR: Our next question comes for Lisa Nichols, of Robinson Humphries.
LISA NICHOLS, ROBINSON HUMPHRIES: Hello. I had a few questions and a follow-up on - first of all, on the revenue projections. Can you give us a better idea how they might play out for the year, as you get to the 10 million by the end of the year? Like how much will be in Q3, and Q4 and Q2?
CROSS: I'll ask Dan to respond to that.
BILICKI: As you heard from our initial discussions, we anticipate 50 percent increase in Q2, over Q1. And to go forward from that, we obviously have to be looking for ranges over two million plus in Q3, and over three million in fourth, in order to achieve the target.
NICHOLS: OK. All right. And, can you give a - well, let's see, I guess I'll ask this one first. Given whatever anomalies might play out, with regards to building inventories, how likely are we to see cost reductions reflected in the P&L?
CROSS: Well, I think you're already seeing cross-reductions reflected in the P&L. Toward our goal of reducing manufacturing costs 20 percent this entire year, we achieved 14 percent of that 20 percent in the first quarter. We will still achieve manufacturing cost reductions, throughout this year. I think you will see improving financials on a gross margin line that are due to improving manufacturing costs.

In regard to building inventory, this is a very controlled inventory build with constant contact to the customer - we have a very good relationship there. We are building inventory very prudently to their forecast and are in almost weekly conversation on this topic. So, we're not concerned at all at this time about the inventory level, relative to what we perceive our customers will take for the sunscreen market, at this time.
NICHOLS: OK. So, as far as where it we'll be on the P&L, will primarily see the improvement in the gross margin line?
BILICKI: Yes.
NICHOLS: All right. You talked a little bit about the environmental - progress of the environmental catalysts, so I wondering if you could provide any further color, as far as an update on how satisfied customers are, or confident you are in developing the business this year and next?
CROSS: The initial tests of this catalyst are quite encouraging. As Dan Bilicki mentioned, going forward there'll be some very large scale testing, but at this point in time the customer and the people who ultimately use this, are quite satisfied, as expected.
NICHOLS: OK. You've talked a lot about what kind of projects you're working on. Can you identify, maybe, the real key projects that you think are going to be generating the greatest results over the next year?
FREED: This is Don Freed. As we mentioned, outside of the healthcare market, which continues to generate substantial revenue for the Company, we believe that the transparent functional coating market - and not just abrasion resistant coatings - but in general, is very promising for Nanophase and will be a significant contributor to our growth. Because of the characteristics of the materials we make, and their small size, and our capabilities of being able to disperse them in a broad variety of matrices and media. There are a very substantial number of applications. And as I said, we ultimately believe that this would be the basis for a separate standalone business, within Nanophase, just relating to transparent functional coating.
CROSS: This is Joe Cross. Let me follow-up on that, just a little bit. As we announced in a previous press release, we have extended our relationship with our largest customers to include the personal care market. We have not yet begun to see, really, the volume that we might expect from penetration of that market by our customer on a global basis. So, we expect growth in that throughout this year and into 2002. But, that's still an early initiative for that customer and we haven't been able to quantify what that means yet.
NICHOLS: OK.
CROSS: The second area I would not want to denigrate is the environmental catalyst area. The opportunity that Don mentioned, that we really can't discuss much about, is a very large opportunity for this Company. The other opportunity the Company's had for sometime, which has to do with environmental catalysts for automotive usage, has a rather serious development program underway with a major player in that market. And we expect to have some success on new materials in the marketplace. We will not know the outcome of those tests until June. So, we have at least four very significant markets, with very strong initiatives, that could seriously add to this Company's revenues, this year and next.
NICHOLS: All right. Thank you very much.
OPERATOR: Again, ladies and gentlemen, to ask a question, press one on your touch-tone telephone. Our next question comes from Loren Ben, of CIBC World Markets.
LOREN BEN, CIBC WORLD MARKETS: Good morning.
BEN:
Joe, do you have an idea - and I know this is a difficult question, because you're working with so many different materials and so many different applications. What type of gross margins do you hope to eventually end up with?
CROSS: That's a good question, because actually the management team spends a lot of time working on this. We expect, over time, that our gross margin should climb to a 60 to 70 percent range. To do that, obviously we would have to have higher margin on sales on our products and we have to continue to decrease our manufacturing costs.

We believe that our leadership position in Nanomaterials is not just the fact that we can make Nanomaterials and encapsulate Nanomaterials with the DPE process, we think that the fact that we are considerably up the learning curve on the manufacturing side puts us ahead of most of our current competitors. That, we believe, is demonstrated by the company shipping over 200 metric tons in 2000 and our success decreasing our costs by 50 percent over the last 15-months.

So, to your question, we think a variable margin of about 70 percent is a number that we can achieve.
BEN: OK - and a follow-up question, if I may. You have significant test quantities in this first quarter. I don't know what percentage they were of the overall. Going forward, do you know how much in your plan is for test quantities, and how much is for actual quantities that are going to be used by the ultimate manufacturer in their products and in their assembly lines, if you will?
BILICKI: Loren, this is Dan Bilicki. As you're aware, and Don mentioned in his presentation, that we're looking at 12 to 18-month time-to- market. And, obviously, there are various stages that you go through, including the value, and the concept and trial stage. Where we are right now is, we've cleared all those hurdles and we're in large trial stage in the environmental catalyst area.

Obviously, at this juncture, until we clear this hurdle - until everyone is comfortable that the product works as expected - we really can't make any comments, on the total market size. However, I must say, that if it is successful the potential is significant, and we're excited about it.
BEN: Well, I guess, I'm not looking to find out what the total market size is in any one contract, or any one application. I think you've probably delineated in your presentations, in the past, what you feel the market size is in certain areas. What I'm trying to figure out is - next quarter you go - you're looking to about a million six. And then you said over two, and then over three. Of the million six - then the two million - three million - going forward. I guess I'm trying to get a feeling as to how much of it is going to be ongoing quantities, as opposed to test quantities.
BILICKI: I understand the question. What we call research materials, which are small amounts of material we sell to customers, primarily in the very early stages of the discussion, and we think that amounts to $35 - $40, 000 per quarter. The other revenue that we're talking about, especially in a production mode, this is well beyond research quantities. These are in product rollouts and product introductions. Probably the earliest would be large-scale pilot testing.
BEN: Right.
BILICKI: So, we don't perceive that anything we're calling production revenue is a research quantity material at all. These are things that are well down the path.
BEN: Stuff that's in pilot manufacturing, though, is not - I mean, they haven't assigned you a part number yet, have they?
DAN BILICKI: That isn't true at all. What it really means is that the customer is ramping up their product production, so the quantities increase over time.
BEN: OK. So then it has been accepted, and they are going to go forward?
BILICKI: Yes, it's just that they're launching maybe their testing in a geographical area, or maybe they're only marketing in, you know, three out of fifty states, or wherever.
BEN: OK.
BILICKI: It's that kind of rollout.
JOE CROSS: But essentially, as we stated for the catalyst order we received, we also have deliveries scheduled for the second quarter in that same product line. So, this is ongoing production. What our customer really doesn't know yet, on an annual basis, is the growth curve and what is the quantity of material requirement yet.
BEN: OK.
OPERATOR: Our next question comes from Steve Springer, of Target Capital Management.
STEVE SPRINGER, TARGET CAPITAL MANAGEMENT: Good morning. Congratulations on an excellent quarter.
JOE CROSS: Thank you, Steve.
SPRINGER: I have three questions. The first is, you have outlined, on a number of occasions, the criteria that Nanophase uses in seeking to establish customer relationships. And so, presumably, before you actually get into the negotiation process, you look at their agenda and your agenda, and if there is compatibility there then you can move forward.

In that context, I'd like to ask you, how many business opportunities are you currently negotiating that have passed that metric?
FREED: Steve, this is Don Freed. There's a broad spectrum of opportunities. Let me just preface it with this - no opportunity that we consider for this Company, will not have passed that. In other words, whatever we work on has to pass our value criteria, and our time-to-market criteria. Otherwise, we just don't do it.

So, the point is, once they pass that, there are probably a dozen or more, in addition to ones that we've already mentioned, that are in various stages, ranging from proof of the feasibility - does it work - can we make the product - can the customer use it - all the way through to a pilot scale production, whatever you call it.

But, I just want to make sure that everyone understands that we will not work on something that doesn't meet our criteria.
SPRINGER: So a dozen or more, of what you might call later stage developments. And how many relationships do you have now - how many existing relationships do you have? That is to say, production relationships.
FREED: Production relationships - like customers to whom we regularly ship products?
SPRINGER: Right.
FREED: I would say, that numbers probably between six and eight.
SPRINGER: OK.
FREED: On an adequate scale to be discussible.
SPRINGER: OK.
FREED: The other thing, Steve, on top of that, we receive 30 to 50 orders for what we call experimental research, in small quantities, on a monthly basis. And that whole list of customer is mined. We look at that very carefully to find out what those people are doing, and do they need to have any help in scaling-up and using more material.
SPRINGER: OK. Next, I'd like to reference the article that appeared in the "Chicago Tribune," on the 23rd of April. And in that article it mentioned - of course, referred to the $5 million annual federal budget for Nanotechnology research, and specifically referenced an initiative on the part of the State of Illinois, to establish a center with funding with as much $150 million - I think it was at Argonne National Labs.

It also talked about Northwestern University's interest in starting up their own research efforts. And it talked about Chicago being possibly a major center for Nanotechnology research. Could you talk a little about how you would benefit from this initiative - from this funding, and what your relationships are with these entities?
FREED: Steve, this is Don Freed again. Long before that press release, and the government's announcement, we had relationships, both with Argonne and with Northwestern.
SPRINGER: Right.
FREED: And they've been centers for Nanotechnology research since the mid 80's. In fact, we have exclusively licensed to Argonne patents, which really belong to Nanophase now. And it was from our Argonne that Dr. Dick Siegel, who is on our Board of Directors, actually founded Nanophase. So, we go back a long way.

As far as the President's budget, that money is really earmarked for federally sponsored research and development by universities - secondary and education - even primary education. The benefit to Nanophase is (A) a greater awareness, not only in the academic community, but also in the research community and in general, of the benefits of Nanotechnology. What that means to us, ultimately, is more customers, more opportunities, and more people who are aware.

In fact, in Germany you can read about Nanotechnology on the back of Kellogg cereal boxes. So, the point is that it raises the level of awareness. It's a long-term benefit - that money is federal grant money. Nanophase won't see that money directly; we'll see it indirectly in increased uses in the Nanomaterials.

But, we're very keenly aware of what goes on, not only in the two places that we mentioned - Argonne and Northwestern - but also in many other places. And it's not only in the State of Illinois, but the State of New York and other states have already started major centers in Nanotechnologies. So you can see that this is really a technology that is key and here to stay.
SPRINGER: Yes, I was aware of the relationship with Argonne. But, what I was really pointing to is the extent to which there maybe an opportunity to license, or acquire, or participate in, new technologies, specially production technologies.

You've talked in the past about looking at other companies, looking at other technologies, and so I'd like to - the third part of my question was, are there any other technology developments, in terms of capabilities, that you would like to acquire, or that you find interesting, at this point?
CROSS: Steve, it's Joe again. There are several technologies that we review frequently. One of the reasons we go to the Nanoparticle conferences is, frankly, just to investigate, and watch papers and see if there's anything interesting. At the last such conference, there was approximately three we found interesting - two we weeded out quickly - the third we're still in discussions with the inventors - that happens to be a European technology.

We haven't seen much technology come in out of the States. And in our perception - and frankly we're presented with most of those technologies, most do not appear to be scalable. There has been a lot of novelty-kind of technologies that we've seen coming from universities and other places that clearly are not scalable, and are clearly non-economical.

But, we remain, we think, fairly well on top of it, not just due to our own efforts, but also by staying in contact with universities. For instance, several of our Board Members are highly involved with Northwestern, so we're pretty much on top of Northwestern and Argonne.

We also have relationships with the university in New York that just started a major Nanoinitiative, part of which is funded by IBM. Also, Dr. Dick Siegel, who is in the Material Department at RPI, stays on top of developments on a global basis and keeps us informed. So, we think we have pretty good tentacles out for a small company. And, yes, we continue to look at technology, and we continue to remain interested and we have no problem at all considering a technology that's invented somewhere that's good for us. We have no problem with licensing or acquiring a company, as long as it's a good business discussion.
SPRINGER: Which is the university in New York that is active is Nanotechnology development?
DON FREED: There's actually two - there's the University of Albany and there's Rensselaer Polytechnic Institute.
SPRINGER: OK. Thank you.
OPERATOR: Our next question comes from Todd Laird of NWQ Investment Management.
TOM LAIRD, NWQ INVESTMENT MANAGEMENT: I guess in a general sense I'm just following-up on the initiatives. I'm wondering in, you know, new business initiatives and exploration of new developments, do you see much competition, or are these usually joint efforts, with existing research internally, with some of these companies? Or, could you just give a little color on that - sort of the competitive landscape?
JOE CROSS: I don't think I would call most of our business development activities really research; I think I would classify them as development, generally with a lead customer. We do have some research projects with lead customers. I would say that most of the projects we work on with customers are co-development between us and the customer, where we typically retain the intellectual property.

Relative to competition, our competition is in two piles. The first is standard materials that are obviously priced much less for a given application. So, we have to show significant value in an application to warrant the price to the customer. For instance, in a wear resistant coating, nanomaterials increase the wear resistance three or four times over normal materials. That's an incredible value, as perceived by our customer.

Relative to other Nanotechnology companies, except in very isolated situations, we do not see competition.
LAIRD: Thank you.
OPERATOR: Our next question comes from Alan Yakuboff of Morgan Stanley.
YAKUBOFF: Just a clarification on the revenue side. You're looking at about a million this quarter - 50 percent up. Next quarter is about two-and-a-half million, or so. So, you're looking at about seven-and-a-half million for the second half of the year. That's almost about three-and-three-quarter million dollars for the next two quarters, on average. You were talking two to three million. Could you just explain that a little further?
JOE CROSS: Well, we think that next quarter ought to be up about 50 percent. We'd expect third quarter to more than double from that and we think the fourth quarter run rate will probably be over four million - if we achieve the 10 to 10-and-a-half million goal, which the Company currently has.
YAKUBOFF: Oh, so you're looking for about three million in the third quarter?
JOE CROSS: Yes, at this point in time.
YAKUBOFF: And somewhere about the four million range then.
JOE CROSS: But, don't forget as you consider this, that we're building inventory right now, especially in sun screen materials, to deliver in the third and fourth quarter. Because the delivery requirements in that market are actually three times - over three times larger than they are in the first quarter of this year. So, it's quite a bulge.
YAKUBOFF: Is that the announcement about pushing it out until the second half of the year made earlier, I think sometime in January?
JOE CROSS: Yes.
YAKUBOFF: Now, that wasn't pushed out to the second half that would have been, more or less, the expectation to be delivered in the second quarter?
JOE CROSS: No. Let me tell the story, as boring as it might be. The customer actually modifies the forecast periodically. The forecast from December 2000, on which we based our initial estimates of revenue and loading for 2001, was relatively level loaded. And that's exactly how we planned our capacity, our manpower, and how we've set our financial budgets.

We were not made aware of the change in the schedule until the end of January, which is when we put the announcement out. And essentially what that did was take material delivery quantity out of the first quarter by almost 50 percent, on the second quarter by about 30 percent, and load all that into the third and fourth quarter. This is due primarily to products being rolled out, in the personal care and sunscreen marketplace, by our customer's schedule.

It's not a slippage in the marketplace, or a reduction in volume; it's simply a change of schedules of rollouts, actually from several different companies.
YAKUBOFF: So you consider those orders to be firm ...
JOE CROSS: Yes, at this point in time.
YAKUBOFF: ... in the second half of the year?
JOE CROSS: We have an annual purchase order from our largest customer in the sunscreen market. And frankly, with life in a manufacturing company, it gets about as firm as you can get.
YAKUBOFF: Thank you.
OPERATOR: Our next question comes from Donald Hutchinson, of Merrill Lynch.
HUTCHINSON: Hi. Some of the comments have prompted some further investigation, I think. I'm curious about the automobile catalyst. I'm aware of the oxide for the cold start burn of those things. Is this the same function, or material, that is being tested through June, or whatever, or is there something in addition to that?
JOE CROSS: No, actually we are working with a major manufacturer in that arena testing various mixed metal oxides for that application. Some of that is propriety technology to this Company - some of it's done in collaboration with this particular company. And the only reason we mention that, frankly, was to show there's a continuing development in technology effort in that particular marketplace.

Relative to the other environmental catalyst initiative that we have going, we're frankly just not able to add any color to that topic at all.
HUTCHINSON: OK. The automobile business, though, is basically we're still in the cold start section of the can there?
JOE CROSS: I can't really discuss that, without violating the secrecy agreement with my customer.
HUTCHINSON: Well, are we still working on the same thing that they were working on from day one on that?
JOE CROSS: We're still in the same general area. We've evolved to broaden that initiative in that area, but we're still in the same general area.
HUTCHINSON: I see. So this is just a refinement of the original objective, it's not something entirely new?
JOE CROSS: No. Don, I think we've got a bit of confusion here. Let me try to clarify it, if I can. The people we are working with for catalytic converters, we're still working with, and we've extended the development effort. The other thing we've announced is not in that area, and we can't say any more about it.
HUTCHINSON: OK. I'm aware of that. I didn't hear where you guys made a guess for next year - would you like to make one?
JOE CROSS: Not particularly. You know, this is kind of like a vineyard - we're not going to crack that cork before its time.
HUTCHINSON: OK. Thank you.
OPERATOR: Our next question comes from Steve Springer, of Target Capital Management.
SPRINGER: Yeah. I'd just like to follow-up on one question, regarding the sunscreens. There have been reports that the FDA is looking into the effect of organic sunscreens on people's skin, in that they were never originally intended to be on the skin all day. And now the cosmetic manufacturers are putting these products in the sunscreens and products they use, from morning to night. And in the context, can you tell me if you're aware of what's going on, in terms of that investigation, and how that might impact the use of inorganic materials, such as yours?
GINA KRITCHEVSKY: Yes, Steve. This is Gina. We are aware of those studies and at this point it's really difficult to predict how it might impact the use of inorganic - you can make a guess.
DON FREED: No, let me add a little bit to this. First of all, there have been some studies that just came out recently from Switzerland, and this has prompted some reaction in Denmark, which indicated a potential ban on organics in daily wear products. This, of course, is being reputed by the sunscreen industry. So, what you can only say about this is watch this space, because a lot will happen, in terms of this situation.

Obviously, if there were some concern the industry would move toward inorganics, which we are well placed to take advantage of. But, at this early stage there is no way we can make a prediction.
SPRINGER: How large is the market for sunscreens, in general?
BILICKI: This is Dan, Steve. If you lumped all the organic and inorganic together, it's close to $400 million. Obviously, the preponderance of that is organic - they've been around a long time. Our own estimate of the inorganic sunscreen market is in the $45 to $50 million range.
SPRINGER: But, the Nanoparticle segment of it is essentially your relationship with BASF - is that correct?
BILICKI: No. There are other inorganic sunscreens, made from titanium dioxide, that are also on the market. There are a number of suppliers of that material. No, it's not just zinc oxide.
SPRINGER: So, Gina, what would be your guess as to how this might play out?
KRITCHEVSKY: I think Dan answered that, Steve. If indeed organic sunscreens are banned, or reduced, then one would suspect people to move to inorganic. But it's really too early to predict that.
CROSS: Steve, this is Joe. This is a very political situation, both in the States and Europe. The FDA's monograph in the States was given a two - I think it was given a two or three-year review period - I can't remember which. And that monograph basically wants to put sunscreens under FDA control, which it is not now. If that should occur, there seems to be, or appears to be, clinical evidence that would concern people about organic sunscreens.

But right now, on both continents, the best we can answer to you in reality - this is a very politically high stakes game, and we really hate to guess as to how this might come out.
SPRINGER: OK. I just have two other questions on the subject. First of all, what are the allegations that you're aware of, as far as what the impact of prolonged exposure to organics is? I mean, it is a serious matter - is it a discoloration of the skin - something more severe?
CROSS: Steve, I don't think we'd like to comment on that. There is conflicting medical evidence, to be really honest with you. None of us purport to be researchers in this field, so I'd really rather not comment on that - that's not our field of expertise, and really that's a serious battle zone right this minute.
SPRINGER: OK. Last question is - are there any inherent advantages to Nanoparticles zinc oxide, as opposed to Nanoparticle titanium dioxide?
GINA KRITCHEVSKY: They absorb - or I should say protect from different portions of the solar spectrum. Yes, there are advantages, depending on which portion of the spectrum that you're exposed to. Zinc oxide is a broader protection than the titanium dioxide.
SPRINGER: OK. Thank you.
OPERATOR: Our next question comes from Loren Ben, of CIBC World Markets.
BEN: Once again, thanks for pulling out a good quarter. CROSS: Thank you.
BEN: And since we were talking about sunscreens, and you also brought up the area of wear resistant specialty fabrics. There's been a lot of conversation lately, regarding the UV qualities of clothing and I was wondering whether - while you were talking to fabric manufactures - if there was anything going on regarding UV protection at the same time?
JOE CROSS: We really can't say at this point.
BEN: OK. Thank you.
OPERATOR: Our next question comes from Todd Cobey, Cobey Jacobson.
TODD COBEY, COBEY JACOBSON: Give us your projections for increased financing, particularly as to the amount you might need and whether - and what your chronological time table would be?
JOE CROSS: Right now, we haven't made any decision on that matter. It is an active discussion inside this Company, as well as on the Board. We have not reached a decision on additional equity, relative to how much, or when. We expect to leave this year with somewhere between $8 and $10 million in cash.

Some of the opportunities that are facing us have different economic impacts that we cannot quite quantify at this point in time, relative to our cash, or relative to contribution by the customer involved. So, I don't think we're prepared to state how much we may need, or when we might need it. I think it's premature at this stage.
COBEY: But, your thoughts are toward equity, rather than short or long-term debt?
JOE CROSS: Our thoughts would tend to run towards equity.
COBEY: Thank you.
OPERATOR: At this time, there appear to be no further questions. Please continue with any closing comments.
CROSS: Ladies and gentlemen, thanks for your attention today, and we'll look forward to talking to you at the end of next quarter. Thank you very much.
OPERATOR: Ladies and gentlemen, thank you for participating in today's conference. This does conclude the program. You may now disconnect. Good day.

Nanophase Technologies Corporation Home Page
Markets | Applications | Products | Product Index | Technologies | Corporate
MSDS Listings | Investor Relations | Employment | Contact Us | Site Map | Search





  © 2008 Nanophase Technologies Corporation
  All Rights Reserved. No part of this site may be reproduced without prior written consent.